1887
Research Open Access
Like 0

Abstract

BACKGROUND

Scabies is a skin disease caused by the mite resulting in intense itching and rash, and sometimes secondary infections with complications. Scabies is not typically a notifiable disease, which makes estimating its burden of disease challenging. In recent years, sharp increases have been reported in Europe.

AIM

This study characterises scabies epidemiology in Spain from 2011 to 2023.

METHODS

This retrospective study triangulated data from primary care, hospital admissions, occupational diagnoses and outbreaks. Annual incidence rates (IRs) were calculated to assess temporal evolution, demographics and geographic distribution. Joinpoint regression identified IR changes, and time-series analysis explored seasonality. Occupational and outbreak data analysis identified high-risk activities and settings.

RESULTS

Incidence rates increased across all data sources, with marked acceleration from 2020–21. The greatest rise was seen in primary care (annual percentage change rose from 22.8% (95% CI: 7.2–31.9) in 2011–20 to 65.8% (95% CI: 47.5–96.6) in 2020–23). The IR was highest amongst 15–24-year-olds. Hospitalisations, with highest IR among people > 65 years, peaked each January. Occupational diagnoses were predominantly registered in healthcare settings (82.0%). Islands and northern coastal regions were most affected. Outbreaks were most frequent in households and nursing homes, with largest outbreaks in healthcare settings.

CONCLUSIONS

Given the increasing incidence of scabies in Spain, a strong response is needed to improve prevention, diagnosis, and treatment. Improved surveillance and targeted public health initiatives could mitigate further spread, as well as further research to better elucidate the mite-related and epidemiological factors that underline the recent increases across Europe.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.47.2500296
2025-11-27
2025-12-08
/content/10.2807/1560-7917.ES.2025.30.47.2500296
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/47/eurosurv-30-47-3.html?itemId=/content/10.2807/1560-7917.ES.2025.30.47.2500296&mimeType=html&fmt=ahah

References

  1. Feldmeier H, Heukelbach J. Epidermal parasitic skin diseases: a neglected category of poverty-associated plagues. Bull World Health Organ. 2009;87(2):152-9.  https://doi.org/10.2471/BLT.07.047308  PMID: 19274368 
  2. Fernando DD, Mounsey KE, Bernigaud C, Surve N, Estrada Chávez GE, Hay RJ, et al. Scabies. Nat Rev Dis Primers. 2024;10(1):74.  https://doi.org/10.1038/s41572-024-00552-8  PMID: 39362885 
  3. Chandler DJ, Fuller LC. A Review of Scabies: An Infestation More than Skin Deep. Dermatology. 2019;235(2):79-90.  https://doi.org/10.1159/000495290  PMID: 30544123 
  4. World Health Organization (WHO). Scabies. Geneva: WHO. [Accessed: 7 Jan 2025]. Available from: https://www.who.int/news-room/fact-sheets/detail/scabies
  5. El-Moamly AA. Scabies as a part of the World Health Organization roadmap for neglected tropical diseases 2021-2030: what we know and what we need to do for global control. Trop Med Health. 2021;49(1):64.  https://doi.org/10.1186/s41182-021-00348-6  PMID: 34399850 
  6. Heukelbach J, Feldmeier H. Ectoparasites--the underestimated realm. Lancet. 2004;363(9412):889-91.  https://doi.org/10.1016/S0140-6736(04)15738-3  PMID: 15032237 
  7. Aždajić MD, Bešlić I, Gašić A, Ferara N, Pedić L, Lugović-Mihić L. Increased scabies incidence at the beginning of the 21st century: what do reports from Europe and the world show? Life (Basel). 2022;12(10):1598.  https://doi.org/10.3390/life12101598  PMID: 36295033 
  8. Sunderkötter C, Aebischer A, Neufeld M, Löser C, Kreuter A, Bialek R, et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019;17(1):15-23.  https://doi.org/10.1111/ddg.13706  PMID: 30480868 
  9. van Deursen B, Hooiveld M, Marks S, Snijdewind I, van den Kerkhof H, Wintermans B, et al. Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021. PLoS One. 2022;17(6):e0268865.  https://doi.org/10.1371/journal.pone.0268865  PMID: 35749401 
  10. Redondo-Bravo L, Fernandez-Martinez B, Gómez-Barroso D, Gherasim A, García-Gómez M, Benito A, et al. Scabies in Spain? A comprehensive epidemiological picture. PLoS One. 2021;16(11):e0258780.  https://doi.org/10.1371/journal.pone.0258780  PMID: 34723979 
  11. Amato E, Dansie LS, Grøneng GM, Blix HS, Bentele H, Veneti L, et al. Increase of scabies infestations, Norway, 2006 to 2018. Euro Surveill. 2019;24(23):190020.  https://doi.org/10.2807/1560-7917.ES.2019.24.23.190020  PMID: 31186078 
  12. Martínez-Pallás I, Aldea-Manrique B, Ramírez-Lluch M, Manuel Vinuesa-Hernando J, Ara-Martín M. Scabies outbreak during home confinement due to the SARS-CoV-2 pandemic. J Eur Acad Dermatol Venereol. 2020;34(12):e781-3.  https://doi.org/10.1111/jdv.16879  PMID: 32810303 
  13. Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, et al. [Translated article] Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermosifiliogr. 2024;115(1):36-47.  https://doi.org/10.1016/j.ad.2023.08.006  PMID: 37923079 
  14. Fernández Camporro Á, Navarro Fernández Í, Arcos González P. [Translated article] Scabies in Spain: Trends in Public Interest and Ectoparasiticide Use. Actas Dermosifiliogr. 2024;115(1):T76-9.  https://doi.org/10.1016/j.ad.2023.10.034  PMID: 37923075 
  15. Martínez-García E, Grau-Pérez M, Buendía-Eisman A, García-Doval I. Prescriptions for scabies are rapidly increasing in Spain: An ecological study with national prescription data, 2008-2021. J Eur Acad Dermatol Venereol. 2023;37(3):e346-7.  https://doi.org/10.1111/jdv.18599  PMID: 36151936 
  16. Laisnez V, Brosius I, Van Bortel W, Meudec M, Janssens A, Madl J, et al. Increasing trend of scabies in Belgium, 2000-2023. Arch Public Health. 2025;83(1):197.  https://doi.org/10.1186/s13690-025-01684-3  PMID: 40731034 
  17. Ministerio de Sanidad. Base de datos clínicos de atención primaria (BDCAP), Sistema Nacional de Salud. [Primary Care Clinical Database (BDCAP), National Health System] Madrid: Gobierno de España. 2014. Spanish. Available from: https://www.sanidad.gob.es/estadEstudios/estadisticas/estadisticas/estMinisterio/SIAP/Diseno_BDCAP.pdf
  18. World Health Organization (WHO). International statistical classification of diseases and related health problems (10th ed.). Geneva: WHO; 2016. Available from: https://icd.who.int/browse10/2016/en
  19. World Health Organization Collaborating Centre (WHOCC) for Drug Statistics Methodology. ATC/DDD Index 2025. Oslo: WHOCC for Drug Statistics Methodology; 2025. Available from: https://www.whocc.no
  20. Ministero de Trabajo y Asuntos Sociales. Orden TAS/1/2007. Boletin Oficial del Estado (BOE). [Official State Gazette]. Madrid: Ministero de Trabajo y Asuntos Sociales; 2007. Spanish. Available from: https://www.boe.es/eli/es/o/2007/01/02/tas1
  21. Instituto Nacional de Estadistica (INE). National Classification of Occupations, CNO-11. Madrid: INE. [Accessed: 9 Jan 2025]. Spanish. Available from: https://www.ine.es/en/daco/daco42/clasificaciones/nota_epa_cno11_en.pdf
  22. Clasificación Nacional de Actividades. CNAE-2009. [National Classification of Professional Activities]. Madrid: Instituto Nacional de Estadistica; 2022. Spanish. Available from: https://www.ine.es/daco/daco42/clasificaciones/cnae09/notasex_cnae_09.pdf
  23. Instituto Nacional de Estadística. INEbase Economically Active Population Survey Latest data. Madrid: Instituto Nacional de Estadística. [Accessed: 21 Mar 2025]. Spanish. Available from: https://www.ine.es/dyngs/INEbase/en/operacion.htm?c=Estadistica_C&cid=1254736176918&menu=ultiDatos&idp=1254735976595
  24. Batra N, Spina A, Blomquist P, Campbell F, Laurenson-Schafer H, Florence I, et al. The Epidemiologist R Handbook. 2021. Available from: https://epirhandbook.com/en
  25. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51.  https://doi.org/10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z  PMID: 10649300 
  26. Reichert F, Schulz M, Mertens E, Lachmann R, Aebischer A. Reemergence of Scabies Driven by Adolescents and Young Adults, Germany, 2009-2018. Emerg Infect Dis. 2021;27(6):1693-6.  https://doi.org/10.3201/eid2706.203681  PMID: 34013873 
  27. Lugović-Mihić L, Aždajić MD, Filipović SK, Bukvić I, Prkačin I, Grbić , et al. An increasing scabies incidence in Croatia: A call for coordinated action among dermatologists, physicians and epidemiologists. Zdr Varst. 2020;59(4):264-72.  https://doi.org/10.2478/sjph-2020-0033  PMID: 33133283 
  28. Spaziante M, Agresta A, D’Amato M, De Carli G, Tonziello G, Vantaggio V, et al. Post-COVID-19 resurgence of scabies’ cases in the Lazio Region, Italy: a new emerging public health threat? Infect Dis Poverty. 2025;14(1):6.  https://doi.org/10.1186/s40249-025-01279-8  PMID: 39905547 
  29. Griffin LR, Pender EK, Laing ME, Markham T. Unexpected consequences of SARS-CoV-2 pandemic: scabies infestation. Clin Exp Dermatol. 2022;47(6):1196-7.  https://doi.org/10.1111/ced.15151  PMID: 35191083 
  30. Laganà A, Saia I, Genovese G, Visalli G, D’Andrea G, Sidoti S, et al. Resurgence of scabies in Italy: The new life of an old disease. Parasite Epidemiol Control. 2024;27:e00392.  https://doi.org/10.1016/j.parepi.2024.e00392  PMID: 39628512 
  31. Zengarini C, Mussi M, La Placa M, Pileri A, Virdi AL, Chessa M, et al. Scabies increasing incidence in Bologna from 2013 to 2024: a retrospective analysis. Sex Transm Infect. 2025;101(4):256-8.  https://doi.org/10.1136/sextrans-2024-056436  PMID: 39880595 
  32. UN Tourism. UN Tourism Data Dashboard. [Accessed: 27 Feb 2025]. Available from: https://www.unwto.org/tourism-data/global-and-regional-tourism-performance
  33. Simonart T, Lam Hoai XL. Escalating threat of drug-resistant human scabies: current insights and future directions. J Clin Med. 2024;13(18):5511.  https://doi.org/10.3390/jcm13185511  PMID: 39336998 
  34. Li FZ, Chen S. Diagnostic accuracy of dermoscopy for scabies. Korean J Parasitol. 2020;58(6):669-74.  https://doi.org/10.3347/kjp.2020.58.6.669  PMID: 33412771 
  35. Liu JM, Wang HW, Chang FW, Liu YP, Chiu FH, Lin YC, et al. The effects of climate factors on scabies. A 14-year population-based study in Taiwan. Parasite. 2016;23:54.  https://doi.org/10.1051/parasite/2016065  PMID: 27905271 
  36. Vangeel W, Defau L, De Moor L. Young households’ diminishing access to homeownership attainment in Europe. Sustainability (Basel). 2023;15(8):6906.  https://doi.org/10.3390/su15086906 
  37. Future Policy Lab. Vivienda para vivir: de mercancía a derecho. [Housing to live in: from merchandise to right]. Future Policy Lab. [Accessed: 12 Feb 2025]. Available from: https://www.futurepolicylab.com/informes/vivienda-para-vivir-de-mercancia-a-derecho
  38. Galván-Casas C, Ortiz-Álvarez J, Martínez-García E, Corbacho-Monné M. [Translated article] Spanish Academy of Dermatology and Venereology (AEDV) expert recommendations for the management of sexual transmitted parasitosis. Scabies, and pediculosis pubis. Actas Dermosifiliogr. 2024;115(5):T475-92.  https://doi.org/10.1016/j.ad.2024.03.016  PMID: 38479688 
  39. Centro Nacional de Epidemiología. Vigilancia epidemiológica de las infecciones de transmisión sexual, 2023. Madrid: Instituto de Salud Carlos III/División de Control de VIH, ITS, Hepatitis virales y Tuberculosis; 2024. Spanish. Available from: https://cne.isciii.es/documents/d/cne/vigilancia_its_1995_2023-2
  40. Apergis N, Delgado FJ, Suárez-Arbesú C. Inequality and poverty in Spain: Insights from a regional convergence analysis. Int J Finance Econ. [Accessed: 11 Feb 2025]. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijfe.2992
  41. Española de Medicamentos A, Sanitarios P. (AEMPS). Ficha Técnica Ivergalen 3mg Comprimidos EFG. [Technical Data Sheet Ivergalen 3mg Tablets EFG]. Madrid: AEMPS; 2023. Spanish. Available from: https://cima.aemps.es/cima/pdfs/es/ft/85728/FT_85728.html.pdf
/content/10.2807/1560-7917.ES.2025.30.47.2500296
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error